Results
|
|
16361.
|
The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging. [electronic resource] by
- Wang, Shengfei
- Niu, Xiaomin
- Bao, Xiao
- Wang, Qin
- Zhang, Jianping
- Lu, Shun
- Wang, Yongjun
- Xu, Ling
- Wang, Mingwei
- Zhang, Jie
Producer: 20190703
In:
Oncology reports vol. 41
Availability: No items available.
|
|
|
16362.
|
Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW 264.7 cells. [electronic resource] by
- Xu, Huanhuan
- Liu, Titi
- Li, Jin
- Xu, Jing
- Chen, Fei
- Hu, Lihong
- Zhang, Banglei
- Zi, Chengting
- Wang, Xuanjun
- Sheng, Jun
Producer: 20200218
In:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol. 118
Availability: No items available.
|
|
|
16363.
|
|
|
|
16364.
|
|
|
|
16365.
|
|
|
|
16366.
|
Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. [electronic resource] by
- Kotake, S
- Udagawa, N
- Hakoda, M
- Mogi, M
- Yano, K
- Tsuda, E
- Takahashi, K
- Furuya, T
- Ishiyama, S
- Kim, K J
- Saito, S
- Nishikawa, T
- Takahashi, N
- Togari, A
- Tomatsu, T
- Suda, T
- Kamatani, N
Producer: 20010607
In:
Arthritis and rheumatism vol. 44
Availability: No items available.
|
|
|
16367.
|
|
|
|
16368.
|
|
|
|
16369.
|
|
|
|
16370.
|
|
|
|
16371.
|
|
|
|
16372.
|
|
|
|
16373.
|
|
|
|
16374.
|
LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. [electronic resource] by
- Nagasawa, T
- Kobayashi, H
- Kiji, M
- Aramaki, M
- Mahanonda, R
- Kojima, T
- Murakami, Y
- Saito, M
- Morotome, Y
- Ishikawa, I
Producer: 20021112
In:
Clinical and experimental immunology vol. 130
Availability: No items available.
|
|
|
16375.
|
|
|
|
16376.
|
|
|
|
16377.
|
|
|
|
16378.
|
|
|
|
16379.
|
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. [electronic resource] by
- Manthey, Carl L
- Johnson, Dana L
- Illig, Carl R
- Tuman, Robert W
- Zhou, Zhao
- Baker, Judith F
- Chaikin, Margery A
- Donatelli, Robert R
- Franks, Carol F
- Zeng, Lee
- Crysler, Carl
- Chen, Yanmin
- Yurkow, Edward J
- Boczon, Lisa
- Meegalla, Sanath K
- Wilson, Kenneth J
- Wall, Mark J
- Chen, Jinsheng
- Ballentine, Shelley K
- Ott, Heidi
- Baumann, Christian
- Lawrence, Danielle
- Tomczuk, Bruce E
- Molloy, Christopher J
Producer: 20100527
In:
Molecular cancer therapeutics vol. 8
Availability: No items available.
|
|
|
16380.
|
|